Want to join the conversation?
In the Hospital segment, on a pro forma basis after adjusting for divestitures, $THC expects EBITDA to increase by 3-5% in 2016. In the Ambulatory segment, EBITDA and EBITDA less NCI are both expected to grow by about 15-20%. $THC expects revenue for Conifer to grow 10-15% to about $1.6Bil in 2016 and for EBITDA to be $265MM.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.